来曲唑、克罗米芬或促性腺激素受孕儿童三年随访
美国多中心前瞻性队列随访PCOS(多囊卵巢综合征)及不明原因不孕女性经来曲唑、克罗米芬或促性腺激素受孕的子代至3岁。来曲唑组MCDI多数条目得分高于促性腺激素组,多胎主要见于促性腺激素组。
要点
- 三组儿童ASQ异常评分在各时间点均无显著差异
- 来曲唑组MCDI短语与手势多数条目得分显著高于促性腺激素组
- 随访中多胎多见于促性腺激素组(n=14),其次克罗米芬(n=6)和来曲唑(n=3)
核心结论
- 一线不孕治疗(含来曲唑)受孕儿童在生长与认知发育速率上的差异较小,可能源于多胎妊娠率的不同。
研究设计与样本
- 前瞻性队列研究,美国学术健康中心,随访PCOS(PPCOS II)与不明原因不孕(AMIGOS)试验中经来曲唑、克罗米芬或促性腺激素受孕的子代。
主要发现
- 三组在ASQ异常评分上各时间点均无显著差异。
- MCDI词语与手势量表中,来曲唑组在短语、早期手势、后期手势及总手势等多数条目得分显著高于促性腺激素组。
- 克罗米芬组在后期手势与总手势条目得分显著高于促性腺激素组。
- 随访中多胎妊娠主要来自促性腺激素组(n=14),其次克罗米芬(n=6)与来曲唑(n=3)。
临床怎么用
- 可为接受来曲唑或克罗米芬促排卵并受孕的家庭提供子代早期发育结局的咨询参考。
- 关注促性腺激素治疗相关多胎妊娠对子代发育评估的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To study the development of children conceived from non-IVF infertility treatments consisting of gonadotropins, clomiphene, or letrozole. DESIGN: Prospective cohort study. SETTING: U.S. academic health centers. PATIENT(S): Children of women with polycystic ovary syndrome who conceived with letrozole (LTZ) or clomiphene (CC) in the PPCOS II study or women with unexplained infertility (AMIGOS study) who conceived with LTZ, CC, or gonadotropin (GN). INTERVENTION(S): Longitudinal annual follow-up from birth to age 3. MAIN OUTCOME MEASURE(S): Scores from Ages and Stages Developmental Questionnaire (ASQ), MacArthur-Bates Communicative Development Inventory (MCDI), and annual growth. RESULT(S): One hundred eighty-five children from 160 families participated in at least one follow-up evaluation from the two infertility trials. Most multiple gestations in the follow-up study resulted from GN treatment (n = 14) followed by CC (n = 6) and LTZ (n = 3). There were no significant differences among the three groups at any time point with respect to abnormal scores on the ASQ. On the MCDI Words and Gestures, the LTZ group scored significantly higher than the GN group for most items (phrases, early gestures, later gestures, and total gestures). Children in the CC group scored significantly higher than the GN group for the later gestures and total gestures items. CONCLUSION(S): Differences in growth and cognitive developmental rates among children conceived with first-line infertility therapies, including LTZ, are relatively minor and likely due to differences in multiple pregnancy rates.
引用
- Legro RS, Diamond MP, Coutifaris C, et al. Pregnancy registry: three-year follow-up of children conceived from letrozole, clomiphene, or gonadotropins. Fertil Steril. 2020. PMID: 32386612. doi:10.1016/j.fertnstert.2019.12.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。